Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/06/1999EP0832900A4 Peptide and method of obtaining it
10/06/1999EP0722326A4 Highly sulfated maltooligosaccharides with heparin-like properties
10/06/1999EP0660705B1 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
10/06/1999EP0597018B1 Glycosidation reaction
10/06/1999EP0584068B1 Method and composition for ameliorating the adverse effects of aging
10/06/1999CN1230998A Three component chimeric antisense oligonucleotides
10/06/1999CN1230962A 3-substituted pyrido [4',3' : 4, 5] thieno [2,3-D] pyrimidine derivatives, their preparation and their use
10/06/1999CN1230960A Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates
10/06/1999CN1230959A N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
10/06/1999CN1230956A Method of producing polyphenol-containing compositions
10/06/1999CN1230955A Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
10/06/1999CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/06/1999CN1230894A Pharmaceutical composition containing a 5HT2C antagonist and A D2 antagonist
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230890A Injectable formulations of avermectins and milbemycins
10/06/1999CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
10/06/1999CN1230888A Oral contraceptive
10/06/1999CN1230887A Reducing toxic effects of carboplatin using dithioethers
10/06/1999CN1230886A Combination therapy for treatment of psychoses
10/06/1999CN1230885A Use of benzopyranols to treat neurological disorders
10/06/1999CN1230884A Thiol sulfone metalloprotease inhibitors
10/06/1999CN1230883A Coated particle formulation
10/06/1999CN1230882A Method and composition for rewetting contact lenses and relieving eye dryness
10/06/1999CN1230875A Flavonol containing food supplements
10/06/1999CN1230549A Escape mutant of surface antigen of hepatitis B virus
10/06/1999CN1230542A Sidechain-bearing taxanes
10/06/1999CN1230429A Medicine for trachitis and its preparation
10/06/1999CN1230415A Combined Chinese and Western medicine for treating nevus and its preparation
10/06/1999CN1230410A Cancer-curing mixed antisense medicine
10/06/1999CN1230409A Phosphonocarboxylate compounds and pharmaceutical compositions containing the same
10/06/1999CN1230408A Compound alkaloid terpene hydrochloride analgesic preparation
10/06/1999CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
10/06/1999CN1230406A Application of benzoic benzylamine amide as bitter agent
10/06/1999CN1230401A Compound non-opium drug abstaining spray
10/06/1999CN1045472C Technology for extracting polyose protein from mushroom using enzyme process and producing polyose protein capsule
10/06/1999CN1045443C Novel purine derivatives and pharmaceutically acceptable salts thereof
10/06/1999CN1045442C Levo- and dextro- chloroscouriline (tetrahydroprotoberberines) and preparation and application thereof
10/06/1999CN1045441C Antifungal agents, processes for the preparation thereof, and intermediates
10/06/1999CN1045440C Process for preparing medicinal preparation containing beta-form thiamine hydrochloride crystals
10/06/1999CN1045438C 4H carbazoleone Mannich base and its synthesizing method and application
10/06/1999CN1045435C Naphthalene derivative, preparation thereof and middle agent syntherised of same
10/06/1999CN1045431C 15-deoxyspergualin analogs, their preparation method, compositions, intermediate and use in preparation of medicine thereof
10/06/1999CN1045391C Oral delivery system
10/06/1999CN1045383C Medicine composition for curing senile cataract
10/06/1999CN1045382C Chloramphenicol eye drop contg. sodium hyaluronic acid and its preparation
10/06/1999CN1045362C Microbicide compositions containing iodide
10/05/1999US5962712 Therapy of disease and stress
10/05/1999US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999US5962701 Heat and oxidation resistance; photostability
10/05/1999US5962698 Plasminogen activator inhibitor
10/05/1999US5962695 Aromatic amidine derivatives and salts thereof
10/05/1999US5962693 Catalytic hydrogenation
10/05/1999US5962686 Fungicides
10/05/1999US5962682 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/05/1999US5962669 Nucleic acid encoding prion protein variant
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962663 Producing biopolymer with high molecular weight and low viscosity by repeatedly contacting fresh crustacean shells with aqueous mineral acid and alkali metal hydroxide solutions
10/05/1999US5962661 Seco compounds from the class of tylosins
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962659 Anthelmintic milbemycins and avermectins
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962535 Composition for alzheimer's disease
10/05/1999US5962534 Regulating gene expression using retinoids with CH2 OH or related groups at the side chain terminal position
10/05/1999US5962532 Therapeutic method with capsaicin and capsaicin analogues
10/05/1999US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents
10/05/1999US5962530 Neuropeptide y antagonist
10/05/1999US5962529 Metalloproteinase inhibitors
10/05/1999US5962528 Administering uretha
10/05/1999US5962527 Method and composition for treating cancers
10/05/1999US5962526 Pharmaceutical compositions containing hydroxycarboxylic acids and/or ketocarboxylic acids and methods of using same
10/05/1999US5962525 6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same
10/05/1999US5962524 For skins
10/05/1999US5962523 Cancer patients undergoing chemotherapy, radiation
10/05/1999US5962522 Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962518 Fungicide
10/05/1999US5962517 Pharmaceutical compositions and methods for treating acne
10/05/1999US5962516 Immunosuppressive compounds and methods
10/05/1999US5962515 Immunomodulators
10/05/1999US5962514 Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
10/05/1999US5962513 Central nervous system, psychological disorders
10/05/1999US5962512 Oil containing 5-methoxypsoralen at a concentration of 60-100 ppm, and its use in treatment of psoriasis
10/05/1999US5962511 Drugs for allergic and eosinophilic diseases
10/05/1999US5962509 Dithiolylidene acetamide derivatives
10/05/1999US5962505 Topical administering a glycopyrrolate compound
10/05/1999US5962504 Activator of protein kinase; anticancer agent
10/05/1999US5962503 Use of cholinesterase inhibitors in the treatment of xerostomia
10/05/1999US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
10/05/1999US5962501 Headaches
10/05/1999US5962500 Insulin sensitivity with angiotensin II receptor blocking imidazoles
10/05/1999US5962499 Acaricidal, antiparasitic, insecticidal and anthelmintic agents
10/05/1999US5962497 A 3,4-diphenyl substituted chroman compound
10/05/1999US5962496 Central nervous system disorders
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962494 Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
10/05/1999US5962493 Hypolipemic agents; anticholesterol agents
10/05/1999US5962492 Antiasthma agents; antiinflammatory agents
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999US5962489 Fungicides
10/05/1999US5962488 Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives